XKRX
246710
Market cap37mUSD
Dec 05, Last price
2,570.00KRW
1D
2.80%
1Q
-8.21%
IPO
-58.71%
Name
T&R Biofab Co Ltd
Chart & Performance
P/E
—
P/S
11.37
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
4.87b
-6.26%
Net income
-7.68b
L-42.78%
CFO
-11.73b
L+68.49%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. It offers craniomaxillofacial meshes, dental meshes, and patient specific implants; and bioinks for 3D bioprinting and cell culture, stem cell research and delivery, and coating of scaffold and cultural dishes. The company was founded in 2013 and is based in Siheung-si, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2024‑12 | 2023‑12 | |
| Income | ||
Revenues | ||
Cost of revenue | ||
Unusual Expense (Income) | ||
NOPBT | ||
NOPBT Margin | ||
Operating Taxes | ||
Tax Rate | ||
NOPAT | ||
Net income | ||
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | ||
BB yield | ||
| Debt | ||
Debt current | ||
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | ||
Net debt | ||
| Cash flow | ||
Cash from operating activities | ||
CAPEX | ||
Cash from investing activities | ||
Cash from financing activities | ||
FCF | ||
| Balance | ||
Cash | ||
Long term investments | ||
Excess cash | ||
Stockholders' equity | ||
Invested Capital | ||
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | ||
Price | ||
Market cap | ||
EV | ||
EBITDA | ||
EV/EBITDA | ||
Interest | ||
Interest/NOPBT | ||